Sebastián Cruz-Gómez

Sebastián Cruz-Gómez

Auto-generated profile, based on publicly available information

Sebastián Cruz-Gómez

Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia 1

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2020 in Science Immunology
Verified
Journal Article
Closed access
PDF file
HFH. Frizzell
H. Frizzell
RFR. Fonseca
R. Fonseca
SCSusan Christo
Susan Christo
MEM. Evrard
M. Evrard
SCS. Cruz-Gomez
S. Cruz-Gomez
LML. K. Mackay
L. K. Mackay
Tissue-resident cells exhibit tissue-specific overlays to the T RM cell residency program that includes flexible FABP isoform selection tailored to the tissue of lodgment.

1 February 2017 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
CFClaudio Figueroa
Claudio Figueroa
FGFelipe Gálvez-Cancino
Felipe Gálvez-Cancino
COCesar Oyarce
Cesar Oyarce
FCFrancisco Contreras
Francisco Contreras
CPCarolina Prado
Carolina Prado
Rodrigo PachecoRodrigo Pacheco
Rodrigo Pacheco

12 October 2017 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
PMPaola Murgas
Paola Murgas
NBNicolás Bustamante
Nicolás Bustamante
NANicole Araya
Nicole Araya
SCSebastián Cruz-Gómez
Sebastián Cruz-Gómez
EJEduardo Felipe Durán Jara
Eduardo Felipe Durán Jara
ALAlvaro Lladser
Alvaro Lladser

13 December 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
COCesar Oyarce
Cesar Oyarce
SCSebastián Cruz-Gomez
Sebastián Cruz-Gomez
FGFelipe Galvez-Cancino
Felipe Galvez-Cancino
PVPablo Vargas
Pablo Vargas
HMHélène D. Moreau
Hélène D. Moreau
ALAlvaro Lladser
Alvaro Lladser
Dendritic cell (DC) trafficking from peripheral tissues to lymph nodes (LNs) is a key step required to initiate T cell responses against pathogens as well as tumors. In this context, cellular membrane protrusions and the actin cytoskeleton are essential to guide DC migration towards chemotactic signals. Caveolin-1 (CAV1) is a scaffolding protein that modulates signaling pathways leading to remodeling of the actin cytoskeleton and enhanced migration of cancer cells. However, whether CAV1 is relevant for DC function and specifically for DC migration to LNs is unknown. Here, we show that CAV1 expression is upregulated in DCs upon LPS- and TNF-α-induced maturation. CAV1 deficiency did not affect differentiation, maturation, or the ability of DCs to activate CD8+ T cells in vitro. However, CAV1-deficient (CAV1−/−) DCs displayed reduced in vivo trafficking to draining LNs in control and inflammatory conditions. In vitro, CAV1−/− DCs showed reduced directional migration in CCL21 gradients in transwell assays without affecting migration velocity in confined microchannels or three-dimensional collagen matrices. In addition, CAV1−/− DCs displayed reduced activation of the small GTPase Rac1, a regulator of actin cytoskeletal remodeling, and lower numbers of F-actin-forming protrusions. Furthermore, mice adoptively transferred with peptide-pulsed CAV1−/− DCs showed reduced CD8+ T cell responses and antitumor protection. Our results suggest that CAV1 promotes the activation of Rac1 and the formation of membrane protrusions that favor DC chemotactic trafficking toward LNs where they can initiate cytotoxic T cell responses.

21 September 2022 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
HLHui Jing Lim
Hui Jing Lim
JWJacinta M. Wubben
Jacinta M. Wubben
CGCristian Pinero Garcia
Cristian Pinero Garcia
SCSebastian Cruz-Gomez
Sebastian Cruz-Gomez
JDJieru Deng
Jieru Deng
HMHamish E.G. McWilliam
Hamish E.G. McWilliam
MR1 is a highly conserved microbial immune-detection system in mammals. It captures vitamin B–related metabolite antigens from diverse microbes and presents them at the cell surface to stimulate MR1-restricted lymphocytes including mucosal-associated invariant T (MAIT) cells. MR1 presentation and MAIT cell recognition mediate homeostasis through host defense and tissue repair. The cellular mechanisms regulating MR1 cell surface expression are critical to its function and MAIT cell recognition, yet they are poorly defined. Here, we report that human MR1 is equipped with a tyrosine-based motif in its cytoplasmic domain that mediates low affinity binding with the endocytic adaptor protein 2 (AP2) complex. This interaction controls the kinetics of MR1 internalization from the cell surface and minimizes recycling. We propose MR1 uses AP2 endocytosis to define the duration of antigen presentation to MAIT cells and the detection of a microbial metabolic signature by the immune system.

2 August 2019 in Cancers
Verified
Journal Article
Open access
PDF file
MAMaximiliano Arce
Maximiliano Arce
MPMauricio Pinto
Mauricio Pinto
MGMacarena Galleguillos
Macarena Galleguillos
CMCatalina Muñoz
Catalina Muñoz
CTCarla Taramasco
Carla Taramasco
GOGareth Owen
Gareth Owen
Hypercoagulable state is linked to cancer progression; however, the precise role of the coagulation cascade is poorly described. Herein, we examined the contribution of a hypercoagulative state through the administration of intravenous Coagulation Factor Xa (FXa), on the growth of solid human tumors and the experimental metastasis of the B16F10 melanoma in mouse models. FXa increased solid tumor volume and lung, liver, kidney and lymph node metastasis of tail-vein injected B16F10 cells. Concentrating on the metastasis model, upon coadministration of the anticoagulant Dalteparin, lung metastasis was significantly reduced, and no metastasis was observed in other organs. FXa did not directly alter proliferation, migration or invasion of cancer cells in vitro. Alternatively, FXa upon endothelial cells promoted cytoskeleton contraction, disrupted membrane VE-Cadherin pattern, heightened endothelial-hyperpermeability, increased inflammatory adhesion molecules and enhanced B16F10 adhesion under flow conditions. Microarray analysis of endothelial cells treated with FXa demonstrated elevated expression of inflammatory transcripts. Accordingly, FXa treatment increased immune cell infiltration in mouse lungs, an effect reduced by dalteparin. Taken together, our results suggest that FXa increases B16F10 metastasis via endothelial cell activation and enhanced cancer cell-endothelium adhesion advocating that the coagulation system is not merely a bystander in the process of cancer metastasis.